Immunization and Pneumococcal Infection
- LAST REVIEWED: 15 December 2016
- LAST MODIFIED: 26 August 2014
- DOI: 10.1093/obo/9780199756797-0136
- LAST REVIEWED: 15 December 2016
- LAST MODIFIED: 26 August 2014
- DOI: 10.1093/obo/9780199756797-0136
Streptococcus pneumoniae, or pneumococcus, is an important bacterial pathogen responsible for serious communicable diseases such as pneumonia, meningitis, and sepsis, mainly affecting young children and the elderly. According to World Health Organization (WHO) estimates, pneumococcus caused 476,000 deaths of children below the age of 5 years worldwide in 2008. The highest case-fatality rates are found in developing countries, where up to 50 percent of young children who develop pneumococcal meningitis can die. Invasive pneumococcal disease (IPD) is defined as a condition when pneumococcus is isolated from sterile body sites such as blood or cerebrospinal fluid; IPD represents the most serious form of this infection. Pneumococcus can also cause less severe disease, such as otitis media or sinusitis; moreover, it can be asymptomatically carried by normal individuals in the upper airways. The polysaccharide capsule surrounding pneumococcus is the major virulence factor, and antibodies specific to the capsule is the principal defense mechanism against the infection. As young children do not have anticapsular polysaccharide antibodies, they are highly susceptible to pneumococcal infection. The elderly, as well as certain categories of individuals with host defense defects, such as primary immunodeficiency, HIV infection, or asplenia, are also vulnerable. Prevention of pneumococcal infection can be achieved through immunization with polysaccharide antigens that will result in the production of protective antibodies. However, there are two major issues with pneumococcal immunization. First, pneumococcus exists in multiple antigenic variants; indeed, there are more than ninety serological types (serotypes) that differ in antigenic properties of the capsular polysaccharides. Since it is not possible at this time to immunize against all the serotypes, the existing vaccines contain capsular polysaccharides of the most prevalent and virulent serotypes, such as 23, 13, or 10 antigens, depending on vaccine formulation. The second issue is that capsular polysaccharides are not immunogenic in children below the age of two years, when humans are most susceptible to pneumococcal infection. Bacterial capsular polysaccharides are T-cell independent antigens, and antibody production critically depends on a specific B-cell subpopulation, which develops in humans after two years of age. To overcome this issue of low immunogenicity of pneumococcal polysaccharides in young children, protein-polysaccharide conjugate vaccines are used for pediatric immunization. In such vaccines, pneumococcal polysaccharides acquire properties of T-cell dependence and they are consequently immunogenic in infants. Currently, two different types of pneumococcal vaccines are available: a 23-valent pneumococcal polysaccharide vaccine, and two conjugate vaccines (13-valent and 10-valent). The latter vaccines are replacing a previously used 7-valent conjugate vaccine.
Textbooks and Reviews
A large number of textbooks and review articles are available that describe various aspects of pneumococcal infection as well as immunization principles to prevent the disease, covering epidemiology, characteristics of the pathogen, existing pneumococcal vaccines, and issues related to the evolving features of the pathogen under current immunization and antibiotic therapy pressure. Only a few recent resources are included in this section, representing an essential reading list on the subject. Tuomanen 2004 is a great introductory reading covering all essential aspects of this infection, including basic science data and historical perspective on the subject. As a more clinically oriented resource, Musher 2010, an entry in a book on infectious diseases, is helpful for both clinicians and public health professionals. Klugman, et al. 2013 and Jackson 2013, two chapters from the book Vaccines (edited by Stanley Plotkin, Walter Orenstein, and Paul Offit), give a comprehensive overview of two major types of pneumococcal vaccines. Klugman, et al. 2013 has a specific focus on pneumococcal conjugate vaccines, including the most recent research and development information in this field, and also provides essential background that helps to understand fundamental issues with vaccine immunogenicity, efficacy, and potential drawbacks. Jackson 2013 describes various aspects of pneumococcal polysaccharide vaccines. American Academy of Pediatrics 2012 provides more specific information on the clinical application of pneumococcal vaccines for pediatricians. Atkinson, et al. 2009 is also an application-oriented book, but it covers both pediatric and adult immunization, including groups at high risk for pneumococcal infection. World Health Organization 2009, a review on global epidemiology, summarizes data on the pneumococcal disease burden in children, covering both pre-vaccine and post-vaccine time, with an emphasis on vaccine impact in developed and developing countries.
American Academy of Pediatrics. 2012. Pneumococcal infections. In Red Book: 2012 report of the Committee on Infectious Diseases. 28th ed. Edited by L. K. Pickering, D. W. Kimberlin, and S. S. Long, 571–582. Elk Grove Village, IL: American Academy of Pediatrics.
This book, prepared by the American Academy of Pediatrics, is designed to provide essential information on vaccine-preventable diseases and current immunization guidelines relevant to clinical practice; it is regularly updated to include all the recent information on immunization.
Atkinson, W., S. Wolfe, J. Hamborsky, and L. McIntyre, eds. 2009. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th ed. Atlanta, GA: Centers for Disease Control and Prevention.
This book is produced by the Education, Information and Partnership Branch, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention. A valuable source for researchers and officers in the public health area.
Jackson, Lisa A. 2013. Pneumococcal polysaccharide vaccines. In Vaccines. 6th ed. Edited by Stanley Plotkin, Walter Orenstein, and Paul Offit, 542–572. Edinburgh: Elsevier/Sounders.
Comprehensive review of pneumococcal polysaccharide vaccines, including historical data, vaccine immunogenicity, and indications. This chapter contains a summary of clinical trials done in various categories of adults and children, including groups at risk of invasive pneumococcal disease, with vaccine efficacy and effectiveness data.
Klugman, Keith P., Steven Black, Ron Dagan, Richard Malley, and Cynthia G. Whitney. 2013. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines. In Vaccines. 6th ed. Edited by Stanley Plotkin, Walter Orenstein, and Paul Offit, 504–541. Edinburgh: Elsevier/Sounders.
This chapter provides essential information on pneumococcal polysaccharide-protein conjugates that are widely used for current immunization against pneumococcal infection. An issue of serotype replacement resulting from increasing prevalence of non-vaccine serotypes is discussed.
Musher, Daniel M. 2010. Pneumococcal infections. In Harrison’s infectious diseases. Edited by Dennis L. Kasper and Anthony S. Fauci, 374–384. New York: McGraw-Hill Medical.
This is a valuable source for medical students, physicians, and public health/infectious disease control personnel. The chapter provides essential information on pneumococcal infection and its prevention.
Tuomanen, Elaine I. 2004. The pneumococcus. Washington, DC: ASM Press.
A comprehensive textbook on pneumococcus and pneumococcal infection that provides both current research data and historical information. A valuable source of information for graduate and medical school students, as well as for infectious disease specialists.
World Health Organization. 2009. Global literature review of Haemophilus influenzae type b and Streptococcus pneumoniae invasive disease among children less than 5 years of age, 1980–2005. Geneva, Switzerland: World Health Organization.
A comprehensive review of literature published between January 1980 and December 2005 on the global invasive pneumococcal disease burden in children, prepared by World Health Organization Department of Immunization, Vaccines and Biologicals. A total of 211 studies are summarized.
Users without a subscription are not able to see the full content on this page. Please subscribe or login.
How to Subscribe
Oxford Bibliographies Online is available by subscription and perpetual access to institutions. For more information or to contact an Oxford Sales Representative click here.
- Access to Health Care
- Action Research
- Active Aging
- Active Living
- Adolescent Risk-Taking Behavior in the United States
- Advocacy, Public Health
- Agricultural Safety and Public Health
- Air Quality: Health Effects
- Air Quality: Indoor Health Effects
- Alcohol Availability and Violence
- Alternative Research Designs
- Ambient Air Quality Standards and Guidelines
- American Perspectives on Chronic Disease and Control
- Antimicrobial Resistance (AMR)
- Asthma in Children
- Attachment as a Health Determinant
- Behavior Change Theory in Health Education and Promotion
- Behavioral Risk Factor Surveillance
- Bicycling and Cycling Safety
- Birth and Death Registration
- Birth Cohort Studies
- Board of Health
- Built Environment and Health, The
- Business and Corporate Practices
- Cancer Communication Strategies in North America
- Cancer Prevention
- Cancer Screening
- Capacity Building
- Capacity Building for NCDs in LMICs
- Capacity-Building for Applied Public Health in LMIC: A US ...
- Cardiovascular Health and Disease
- Child Maltreatment
- Children, Air Pollution and
- Children, Injury Risk-Taking Behaviors in
- Children, Obesity in
- Citizen Advisory Boards
- Climate Change and Human Health
- Climate Change: Institutional Response
- Clinical Preventive Medicine
- Community Air Pollution
- Community Development
- Community Gardens
- Community Health Assessment
- Community Partnerships and Coalitions
- Community-Based Participatory Research
- Complexity and Systems Theory
- Culture and Public Health
- Definition of Health
- Dental Public Health
- Design and Health
- Dietary Guidelines
- Ecological Approaches
- Enabling Factors
- Environmental Laws
- Environmental Protection Agency
- Ethics of Public Health
- Evidence-Based Public Health Practice
- Family Planning Services and Birth Control
- Food Safety
- Food Security and Food Banks
- Food Systems
- Frail Elderly
- Functional Literacy
- Genomics, Public Health
- Geographic Information Systems
- Geography and Health
- Global Health
- Global Health Diplomacy
- Global Health Promotion
- Guide to Community Preventive Services, The
- Health Administration
- Health Communication
- Health Disparities
- Health Education
- Health Impact Assessment
- Health in All Policies
- Health in All Policies in European Countries
- Health Literacy
- Health Literacy and Non-Communicable Diseases
- Health Measurement Scales
- Health Planning
- Health Promoting Hospitals
- Health Promotion
- Health Promotion Foundations
- Health Promotion Workforce Capacity
- Health Promotion Workforce Capacity
- Healthy People Initiative
- Hepatitis C
- High Risk Prevention Strategies
- Human Rights, Health and
- Immigrant Populations
- Immunization and Pneumococcal Infection
- Indigenous Peoples, Public Health and
- Indigenous Populations of North America, Australasia, and ...
- Indoor Air Quality Guidelines
- Internet Applications in Promoting Health Behavior
- Intersectoral Strategies in Low - Middle Income Countries ...
- Justice, Social
- Knowledge Translation and Exchange
- Knowledge Utilization and Exchange
- Law of Public Health in the United States
- Media Advocacy
- Mental Health
- Mental Health Promotion
- Migrant Health
- Motor Vehicle Injury Prevention
- Multi-Drug-Resistant Tuberculosis
- National Association of Local Boards of Health
- National Public Health Institutions
- Needs Assessment
- Obesity Prevention
- Occupational Cancers
- Occupational Exposure to Benzene
- Occupational Exposure to Erionite
- Occupational Safety and Health
- Oral Health Equity for Minority Populations in the United ...
- Ottawa Charter
- Parenting and Work
- Parenting Skills and Capacity
- Participatory Action Research
- Patient Decision Making
- Pesticide Exposure and Pesticide Health Effects
- Physical Activity and Exercise
- Physical Activity Promotion
- Polio Eradication in Pakistan
- Population Aging
- Population Determinants of Unhealthy Foods and Beverages
- Population Health Objectives and Targets
- Precautionary Principle
- Prenatal Health
- Program Evaluation in American Health Education
- Program Planning and Evaluation
- Public Health, History of
- Public Health Surveillance
- Public-Private Partnerships in Public Health Research and ...
- Public-Private Partnerships to Prevent and Manage Obesity ...
- Quantitative Microbial Risk Assessment
- Radiological and Nuclear Emergencies
- Randomized Controlled Trials
- Real World Evaluation Strategies
- Reducing Obesity-Related Health Disparities in Hispanic an...
- Research Integrity in Public Health
- Resilient Health Systems
- Rural Health in the United States
- Safety, Patient
- School Health Programs in the Pacific Region
- Sex Education in HIV/AIDS Prevention
- Skin Cancer Prevention
- Smoking Cessation
- Social Determinants of Health
- Social Epidemiology
- Social Marketing
- Statistics in Public Health
- STI Networks, Patterns, and Control Strategies
- Systems in the United States, Public Health
- Systems Modeling and Big Data for Non-Communicable Disease...
- Systems Theory in Public Health
- Traditional, Complementary, Alternative, and Integrative M...
- Translation of Science to Practice and Policy
- Traumatic Stress and Post-Traumatic Stress Disorder
- Tuberculosis among Adults and the Determinants of Health
- Unintentional Injury Prevention
- Urban Health
- Vaccine Hesitancy
- Violence Prevention
- Water Quality
- Water Quality and Water-Related Disease
- Weight Management in US Occupational Settings
- Welfare States, Public Health and Health Inequalities
- Worksite Health Promotion
- World Health Organization (WHO)